NAN:ASX
Nanosonics Ltd.
A$2.84
arrow_upward
+1.43%(+0.040) 1D
Oct 9, 4:10:30 PM GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NAN...
Open
A$2.80
High
A$2.87
Low
A$2.76
Mkt. cap
849.64M
Avg. vol.
1.17M
Volume
905.74K
P/E ratio
49.19
52-wk high
A$4.76
52-wk low
A$2.64
EPS
A$0.06
Shares outstanding
299.17M
No. of employees
508
Open
A$2.80
High
A$2.87
Low
A$2.76
Mkt. cap
849.64M
Avg. vol.
1.17M
Volume
905.74K
P/E ratio
49.19
52-wk high
A$4.76
52-wk low
A$2.64
EPS
A$0.06
Shares outstanding
299.17M
No. of employees
508
News stories
From web sources and news partners
TipRanks
·
1 day ago
Nanosonics Continues Daily On-Market Share Buy-Back Program
TipRanks
·
2 days ago
Nanosonics Updates Market on Ongoing On-Market Share Buy-Back
AD HOC NEWS
·
3 days ago
RBC raises target for Nanosonics stock from AUD 3.00 to AUD 3.75
Profile
Nanosonics is an ASX-listed company in the healthcare industry which manufactures and distributes ultrasound probe disinfectors and other related technologies. It has offices in Australia, the U.S. and Canada, the United Kingdom and Europe, employing more than 300 people.
The company's Trophon is the product used to reduce the spread of Healthcare Acquired Infections. Its Trophon2 product includes AcuTrace technology, which enables digital record keeping and provides workflows for ultrasound probe high level disinfection. Wikipedia
About Nanosonics Ltd.
CEOMichael Kavanagh
Employees508
Founded2001
HeadquartersSydney, New South Wales, Australia
SectorMedical device
Websitenanosonics.com.au